<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="141191">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01854983</url>
  </required_header>
  <id_info>
    <org_study_id>2012-0693</org_study_id>
    <nct_id>NCT01854983</nct_id>
  </id_info>
  <brief_title>Significance of Fluorescence Colposcopy With Autofluorescence Imaging for Cervical Cancer</brief_title>
  <official_title>Clinical Trial to Access Significance of Fluorescence Colposcopy With Autofluorescence Imaging for the Screening of Cervical Cancer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asan Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Asan Medical Center</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Clinical Trial to access Significance of fluorescence colposcopy with autofluorescence
      imaging for the screening of cervical cancer
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      1. Perform pelvic vaginal exam of the subjective to know symptom, illness history,
           physical exam and basal state before fluorescence colposcopy.

        2. Observe acetowhite epithelium and perform biopsy  at suspicious lesion during
           fluorescence colposcopy.

        3. Perform fluorescence colposcopy again after biopsy and confirm extraordinary reaction.

        4. After 1~2weeks follow up the subjective at opd and confirm biopsy result.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2013</start_date>
  <completion_date type="Anticipated">December 2013</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>fluorescence colposcopic result</measure>
    <time_frame>2weeks after fluorescence colposcopy</time_frame>
    <safety_issue>Yes</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Cervical Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        tertiary center
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. age : 20-65 years

          2. abnormal cervical papanicolaou smear , no other specific cervical disease

          3. subject to colposcopic biopsy or LEEP

          4. signed voluntarily to informed concents with full knowledge after explanation abot
             objective, method, contents

        Exclusion Criteria:

          1. pregnant women

          2. porphyria

          3. severe cervical bleeding

          4. genital chlamydia, gonorrhea infection

          5. other drug user with possible interaction (e.g. photosensitizer)

          6. no informed consent
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jeong-Yeol Park, M.D., Ph.D.</last_name>
    <role>Study Chair</role>
    <affiliation>Asan Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jeong-Yeol Park, M.D., Ph.D.</last_name>
    <phone>+82-2-3010-3628</phone>
    <email>catgut1-0@hanmail.net</email>
  </overall_contact>
  <location>
    <facility>
      <name>Asan Medical Center</name>
      <address>
        <city>Seoul</city>
        <zip>138-736</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jeong-Yeol Park, M.D., Ph.D.</last_name>
      <phone>+82-2-3010-3628</phone>
      <email>catgut1-0@hanmail.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2013</verification_date>
  <lastchanged_date>May 14, 2013</lastchanged_date>
  <firstreceived_date>May 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Asan Medical Center</investigator_affiliation>
    <investigator_full_name>Jeong-Yeol Park</investigator_full_name>
    <investigator_title>clinical assistant professor</investigator_title>
  </responsible_party>
  <keyword>fluorescence colposcopy</keyword>
  <keyword>cervical cancer</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Uterine Cervical Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
